Companies: 10,795·Total market cap: $144.5T
Morphic Holding, Inc.

Morphic Holding, Inc.

MORFNASDAQHealthcare
$56.99
+$0.02(+0.04%)
Market Cap$2.9B
P/E Ratio
52W High$57.0
52W Low$19.345

Morphic Holding, Inc. (MORF) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · MORF · as of Sep 30, 2024

Ownership Breakdown

Institutions 0.03%
Insiders 32.5%
Public 67.47%

2

Institutional Holders

▼ 137 vs Q2

$481,070

Total Inst. Value

▼ $1.54B vs Q2

50.22M

Shares Outstanding

freeFloat 67.50%

14,000

13F Shares Held

▼ 45.24M vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

MORF largest shareholders · institutional ownership

Q3 2024 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

DEKABANK DEUTSCHE GIROZENTRALE

pharmaceutical preparations

13.0K2.60%

2.60%

$447.00MOct 24, 2024— held

HOEY INVESTMENTS, INC

pharmaceutical preparations

1.0K0.20%

0.20%

$34.07MOct 28, 2024— held

US BANCORP \DE\

pharmaceutical preparations

00.00%

0.00%

$0Oct 28, 2024EXIT

BANK OF AMERICA CORP /DE/

pharmaceutical preparations

00.00%

0.00%

$0Nov 14, 2024EXIT

WELLS FARGO & COMPANY/MN

pharmaceutical preparations

00.00%

0.00%

$0Nov 13, 2024EXIT

NORTHERN TRUST CORP

pharmaceutical preparations

00.00%

0.00%

$0Nov 13, 2024EXIT

ROTHSCHILD INVESTMENT LLC

pharmaceutical preparations

00.00%

0.00%

$0Oct 18, 2024EXIT

PRICE T ROWE ASSOCIATES INC /MD/

pharmaceutical preparations

00.00%

0.00%

$0Nov 14, 2024EXIT

STATE STREET CORP

pharmaceutical preparations

00.00%

0.00%

$0Nov 14, 2024EXIT

FRANKLIN RESOURCES INC

pharmaceutical preparations

00.00%

0.00%

$0Nov 27, 2024EXIT

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2024 vs prior quarter

Q3 2024

Net institutional sentimentBearish — more selling than buying

0

Increased

+0 shares

0

New Positions

first time holders

0

Decreased

−0 shares

48

Sold Out

fully exited

Net shares change (top 50)

+0

+0 / −0

Net new holders

-48

0 new / 48 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

MORF insider trading · insider activity

Source: SEC Form 4

5

Buy transactions

12

Sell transactions

0.42

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

Edwards Martin

director

Aug 16, 2024D-Return2,376$0.00$0.2380Form 4 ↗

Edwards Martin

director

Aug 16, 2024D-Return17,550$24.49$429.8K0Form 4 ↗

Edwards Martin

director

Aug 16, 2024D-Return12,535$56.47$707.9K0Form 4 ↗

Edwards Martin

director

Aug 16, 2024D-Return23,168$30.52$707.1K0Form 4 ↗

Edwards Martin

director

Aug 16, 2024D-Return9,996$64.79$647.6K0Form 4 ↗

Edwards Martin

director

Aug 16, 2024D-Return24,000$31.00$744.0K0Form 4 ↗

SLATTERY JOSEPH P

director

Aug 16, 2024D-Return12,000$22.96$275.5K0Form 4 ↗

SLATTERY JOSEPH P

director

Aug 16, 2024D-Return12,535$56.47$707.9K0Form 4 ↗

SLATTERY JOSEPH P

director

Aug 16, 2024D-Return24,000$15.00$360.0K0Form 4 ↗

SLATTERY JOSEPH P

director

Aug 16, 2024D-Return9,615$64.79$623.0K0Form 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Morphic Holding, Inc. (MORF) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 32.50%, while retail and public investors account for the remaining 67.47%.

The largest institutional shareholder of Morphic Holding, Inc. is DEKABANK DEUTSCHE GIROZENTRALE, holding approximately 13,000 shares — equal to 2.60% of outstanding shares — as of September 30, 2024.

A total of 2 institutional investors currently hold MORF stock, with a combined institutional value of approximately $481,070 as of the most recent 13F filing period.

Frequently asked questions

MORF ownership

Morphic Holding, Inc. (MORF) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is DEKABANK DEUTSCHE GIROZENTRALE with a 2.60% stake. Company insiders hold 32.50%. Data sourced from SEC Form 13F as of September 30, 2024.

who owns MORF stockMORF ownership structureSEC Form 13F institutional holdingsMORF float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2024